Artificial Intelligence (AI), particularly large language models (LLMs), has shaped public discourse in healthcare technology. However, the reality of regulated medical systems is fundamentally different. Safety, predictability, and accountability are not optional—they are legislative and regulatory obligations.
This distinction gives rise to machine-augmented medical systems: solutions that leverage machine learning (ML) models as transparent, assistive components within tightly controlled clinical workflows, not as autonomous black boxes.
In medicine, unpredictability or inaccuracy can directly harm patients. Therefore, regulatory frameworks demand far stricter standards than consumer AI.
Aspect | European Union | United States |
---|---|---|
Primary Regulation | MDR 2017/745 (Medical Device Regulation) | FDA Medical Device Regulation (21 CFR) |
Software Lifecycle | IEC 62304 compliance mandatory | FDA SaMD guidance & Total Product Lifecycle approach |
Quality Management | ISO 13485 (QMS) | QMS aligned with FDA’s QSR and ISO 13485 |
Risk Management | ISO 14971 required | Risk-based approach in premarket submissions |
Future AI Regulation | EU AI Act (High-Risk AI, incl. medical) | FDA Good Machine Learning Practice (GMLP) draft guidance |
Quality management system for medical devices. Required for manufacturers and developers of SaMD.
Framework for risk management of medical devices, ensuring that hazards from ML outputs are identified and mitigated.
Software development lifecycle standard, mandatory for medical software including ML-augmented systems.
Software quality model covering non-functional requirements: reliability, maintainability, usability, and security.
While LLM-driven AI continues to dominate headlines, regulated medical systems demand higher accuracy, predictability, and compliance. Machine-augmented medical systems provide the middle path: leveraging ML’s strengths within frameworks of transparency, accountability, and trust.